Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus.Adamas Pharmaceuticals announced its $450 million acquisition…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Alejandro Girola
…
This content is for Standard 1 Year members only. LoginJoin Now